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Axonal Transport of Amyloid Precursor Protein
Is Mediated by Direct Binding to the Kinesin
Light Chain Subunit of Kinesin-I
how APP interacts with components of the neuronal
kinesin-I transport machinery.
Kinesin-I was the first member of the kinesin super-
family to be identified (Brady, 1985; Vale et al., 1985)
and is responsible for ATP-dependent movement of ve-
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sicular cargoes within cells (reviewed in Goldstein andSchool of Medicine
Philip, 1999; Goldstein and Yang, 2000; Kamal andUniversity of California, San Diego
Goldstein, 2000). Kinesin-I is composed of two kinesin9500 Gilman Drive
heavy chain (KHC) and two kinesin light chain (KLC)La Jolla, California 92093
subunits. In mouse, there are three genes encoding KHC
(KIF5A, KIF5B, and KIF5C) and three genes encoding
KLC (KLC1, KLC2, and KLC3) (Rahman et al., 1998; XiaSummary
et al., 1998). These KHC and KLC subunits appear to
associate in all possible combinations (Rahman et al.,We analyzed the mechanism of axonal transport of
1998; Xia et al., 1998). KIF5A and KIF5C are neuron-the amyloid precursor protein (APP), which plays a
specific isoforms, whereas KLC1 is neuronally enriched.major role in the development of Alzheimer’s disease.
KIF5B and KLC2 are ubiquitously expressed; the expres-Coimmunoprecipitation, sucrose gradient, and direct
sion pattern of KLC3 is unknown.in vitro binding demonstrated that APP forms a com-
Both KHC and KLC have distinct conserved domains.plex with the microtubule motor, conventional kinesin
KHC has an N-terminal motor domain (Yang et al., 1989),(kinesin-I), by binding directly to the TPR domain of
a central a-helical coiled-coil stalk domain (de Cuevasthe kinesin light chain (KLC) subunit. The estimated
et al., 1992; Gauger and Goldstein, 1993; Hirokawa etapparent Kd for binding is 15–20 nM, with a binding
al., 1989), and a globular C-terminal tail domain, perhapsstoichiometry of two APP per KLC. In addition, associ-
involved in cargo binding (Skoufias et al., 1994; Bi et al.,ation of APP with microtubules and axonal transport
1997; Seiler et al., 2000) or motor regulation (Coy etof APP is greatly decreased in a gene-targeted mouse
al., 1999; Friedman and Vale, 1999; Stock et al., 1999;mutant of the neuronally enriched KLC1 gene. We pro-
Hackney and Stock, 2000). KLC has a conserved N-ter-pose that one of the normal functions of APP may be
minal coiled-coil domain that binds KHC (Gauger andas a membrane cargo receptor for kinesin-I and that
Goldstein, 1993; Diefenbach et al., 1998), and a C-termi-KLC is important for kinesin-I-driven transport of APP
nal domain that consists of 6 imperfect repeats of ainto axons.
34 amino acid tetra-trico peptide repeat (TPR) module
(Gindhart and Goldstein, 1996). Although the functionIntroduction
of the TPR domain in KLC is unknown, TPR domains
are involved in protein–protein interactions in a largeAlzheimer’s disease (AD) is a progressive, neurodegen-
group of structurally and functionally diverse proteinserative disorder characterized by extracellular deposi-
(Lamb et al., 1995; Blatch and Lassie, 1999) and couldtion of amyloid protein. The amyloid deposits are mainly
thus be involved in linking KLC to receptor proteins incomposed of an insoluble peptide, the amyloid-b pep-
vesicular or organellar cargoes. Whether KLC interactstide (Ab), which is derived from proteolytic cleavage of
directly with membrane-associated receptor proteins in
the amyloid precursor protein (APP). Numerous studies
vesicles and what the identity of such motor binding
suggest that aberrant trafficking or processing of APP
receptor proteins might be is unknown.
may play a causative role in AD (reviewed in Selkoe, Previously, a candidate kinesin-I receptor protein
1999; Sinha and Lieberburg, 1999; De Strooper and An- called kinectin (Toyoshima et al., 1992; Kumar et al.,
naert, 2000). Thus, understanding the normal mecha- 1995) was described and found to be largely absent
nisms of axonal transport and trafficking of APP is es- from axons (Toyoshima and Sheetz, 1996). Thus, kinec-
sential to elucidating how APP participates in the tin cannot support transport of APP and other proteins
development of AD. used at nerve termini. Since some recent experiments
In neurons, APP is transported within axons by fast have suggested that “cargo” molecules themselves
anterograde axonal transport from the neuronal cell might interact directly with microtubule-dependent mo-
bodies to the distal nerve terminals (Koo et al., 1990; tor proteins (Tai et al., 1999; Bowman et al., 2000), we
Sisodia et al., 1993). Antisense inhibition experiments investigated the association of APP with the KLC subunit
using oligonucleotides complementary to kinesin heavy of kinesin-I. Our data suggest that APP transport from
chain coding sequences in hippocampal neurons sug- sites of synthesis in the neuronal cell body to sites of
gested that axonal transport of APP requires the micro- utilization or pathogenesis at the axonal terminus is me-
tubule-dependent motor protein kinesin-I (Ferreira et al., diated by direct binding of APP to KLC.
1993; Amaratunga et al., 1995; Yamazaki et al., 1995;
Kaether et al., 2000). However, a prominent gap in our Results
knowledge is the lack of information about whether or
APP Exists in a Complex with Kinesin-I
To investigate whether kinesin-I exists in a complex with* To whom correspondence should be addressed (e-mail: lgoldstein@
ucsd.edu). APP, we conducted coimmunoprecipitation experi-
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Figure 1. APP Exists in a Complex with Kinesin-I
(A) Coimmunoprecipitation of APP with kinesin-I subunits from mouse brain and sciatic nerve extracts. Mouse brain (left panel) or sciatic
nerve (right panel) extracts were immunoprecipitated with no antibody (No Ab) control, the 63-90 antibody (which recognizes both KLC1 and
KLC2), antibodies to KIF5B (ubiquitous KHC), APP (C-terminal polyclonal antibody), or synaptotagmin. Equal amounts of the immunoprecipitate
(IP) and the remaining supernatant (Supe) were loaded onto SDS–polyacrylamide gels, and then analyzed by Western blots using 63-90, APP
(22C11), synaptotagmin (SYT), dynein intermediate (DIC), and synaptophysin (SYP) antibodies.
(B) Specificity of kinesin-I coimmunoprecipitation with APP. Coimmunoprecipitation of APP with KLC from wild-type (wt) and mutant (–/–)
KLC1 brain extracts was done using 63-90 or antibodies specific to either KLC1 or KLC2, and then analyzed by Western blots using either
63-90 or APP (22C11) antibodies.
(C) KLC1 dependence of KHC complexes with APP. Coimmunoprecipitation of APP with KHC from wild-type (wt) and mutant (2/2) KLC1
brain extracts was done using antibodies to three different KHC subunits (KIF5A, KIF5B, and KIF5C), and then analyzed by Western blots
using either 63-90 or APP (22C11) antibodies.
ments from mouse brain and sciatic nerve extracts using shown), suggesting that this interaction is relatively
robust.antibodies to kinesin-I subunits and APP (Figure 1). Ini-
tially, we used two different kinesin-I antibodies includ- We also noticed that a prominent difference between
the coimmunoprecipitations from brain versus sciaticing the monoclonal antibody 63-90 (Stenoien and Brady,
1997), which recognizes both KLC1 and KLC2, and a nerve extracts was that in the sciatic nerve extracts, a
substantially larger fraction of the APP was broughtpolyclonal antibody directed to the ubiquitous KHC sub-
unit (KIF5B). In brain and sciatic nerve extracts, both down relative to the brain extracts. Since the sciatic
nerve is highly enriched for sensory and motor nervekinesin-I antibodies coimmunoprecipitated APP in addi-
tion to kinesin-I subunits (Figure 1A). In contrast, the no axons and lacks nerve cell bodies (although Schwann
cells and a few other nonneuronal cell types are present),antibody controls or a synaptotagmin antibody brought
down no detectable APP or kinesin-I. In the complemen- it is relatively enriched in the actively moving component
of neuronal cargoes. Thus, these results raise the possi-tary coimmunoprecipitation experiment, a polyclonal
anti-APP antibody directed against the last 9 residues bility that much of the APP in the actively transported
compartment of neurons exists in a transport complexof the C terminus of APP precipitated significant
amounts of APP and kinesin-I subunits. To test further with kinesin-I, whereas in whole brain there may be
pools of APP that are pre- or posttransport and thereforethe specificity of the coimmunoprecipitations, we also
probed the immunoprecipitates with antibody probes not associated with kinesin-I.
To evaluate further the specificity of the coimmuno-recognizing synaptotagmin and synaptophysin, which
are synaptic vesicle membrane proteins proposed to be precipitation experiments, similar experiments were
conducted (Figure 1B) using brain extracts made fromcargoes for a different kinesin superfamily motor called
UNC104/KIF1A (Otsuka et al., 1991; Okada et al., 1995; a gene-targeted mouse mutant of KLC1 (Rahman et al.,
1999). We observed that the 63-90 antibody immunopre-Yonekawa et al., 1998) and for the retrograde motor
dynein. None of these proteins coimmunoprecipitated cipitated significantly less APP from the mutant KLC1
mouse brains compared to the wild type. Since the 63-with kinesin-I or APP, thus demonstrating the specificity
of the coimmunoprecipitations between kinesin-I and 90 antibody brings down both KLC1 and KLC2, we also
did coimmunoprecipitation experiments with antibodiesAPP. Addition of 500 mM NaCl to the immunoprecipita-
tion experiments had no apparent effect on the observed (Rahman et al., 1998) specific for either KLC1 or KLC2.
As expected, a KLC1 antibody brings down APP in wildcoimmunoprecipitation of APP and kinesin-I (data not
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type, but not in mutant KLC1 mice. The KLC2 antibody
immunoprecipitates equivalent amounts of APP in wild-
type and mutant KLC1 mice, suggesting that APP can
interact with KLC2 as well as KLC1. To confirm that
APP can interact with both KLC1 and KLC2, three KHC
antibodies (KIF5A, KIF5B, and KIF5C) were used to
coimmunoprecipitate APP from wild-type and mutant
KLC1 brain extracts (Figure 1C). Although all three KHC
antibodies were able to coimmunoprecipitate APP from
both genotypes, the amount of APP associated with
KIF5B is reduced slightly in the KLC1 mutant, whereas
there is a significant decrease in the amount of APP that
comes down with the KIF5C antibody. The amount of
APP that comes down with KIF5A is unchanged in wild
type versus the KLC1 mutant. These results suggest
that association of KIF5B or KIF5C with APP depends
to a greater extent on KLC1 than KLC2, while association
with KIF5A depends to a greater extent upon KLC2 than
KLC1. Taken together, however, the data support the
conclusion that coimmunoprecipitation of kinesin-I and
APP is due to the formation of a complex in vivo, as
opposed to nonspecific contamination of immunopre-
cipitates by APP, and that APP interacts with both
KLC1and KLC2. Intriguingly, these data raise the possi-
bility that the interaction of kinesin-I with APP might
vary among different combinations of KHC and KLC
subunits; further work is necessary to evaluate this sug-
gestion.
We also examined the association of APP and KLC1
in sucrose gradients of membrane proteins from mouse
brain extracts (Figure 2). When wild-type gradient frac-
tions from mouse brain were probed with the KLC anti-
body 63-90, the KLC1 peak migrated around 9S (frac-
tions 7–9), whereas the KLC2 peak migrated around
10.7S (fractions 8–10) as previously reported (Rahman
Figure 2. Cosedimentation of APP with KLC1 in Sucrose Gradients
et al., 1999). Interestingly, similar to KLC1 and KLC2, Is Disrupted in the KLC1 Mutant
APP also peaked around 9S–10S in wild-type mouse Membrane-bound proteins from wild-type (wt) or mutant (2/2) KLC1
brain extracts, overlapping both KLC1 and KLC2. In con- mouse brains were top loaded onto 5%–20% linear sucrose gradi-
trast, in the KLC1 mutant, APP shifted to a higher sedi- ents to separate protein complexes by velocity sedimentation. Frac-
mentation velocity that overlaps substantially with tions were collected and protein samples analyzed by quantitative
Western blotting using antibodies to KLC (63-90) and APP (22C11).KLC2, suggesting that in the absence of KLC1, there is
The percentage of total KLC1, KLC2, and APP in each fractiona shift to an association primarily with KLC2. The KLC2
was calculated for wild-type (circles) and mutant (triangles) KLC1profile is unchanged in the mutant compared to wild-
sucrose gradients. Control protein markers were run in parallel gra-
type as previously reported (Rahman et al., 1999). To dients; the enzyme activity of alcohol dehyrogenase (7S) was at
ensure that the sedimentation profile was not changed fraction 6, catalase (11.3S) was at fraction 9–10, and b-galactosidase
for all proteins in the gradients from the KLC1 mutant, (16S) was at fraction 13–14 (data not shown).
we probed for two other membrane proteins (synapto-
tagmin and synaptophysin) in these gradients and found
that they were unchanged from wild type (data not APP from fraction 8 of KLC1 mutant gradients (data not
shown). It is interesting that soluble kinesin has been shown).
previously reported to exist in two forms: a 6S form
(activated and unfolded) and a 9S form (repressed and
Association of APP with Microtubulesfolded) (Hackney et al., 1992; Stock et al., 1999). We
Is Dependent on KLCsuggest that the APP-KLC complex extracted from
To assess whether APP can associate with microtu-membrane fractions that sediments at 9S is a shifted
bules and whether this interaction was dependent on6S complex, thus explaining why the complex is running
KLC, we conducted in vitro microtubule binding assaysat the same position as the soluble kinesin-I at 9S. Con-
from detergent-treated extracts of wild-type and mu-sistent with this view, we were able to coimmunoprecipi-
tant KLC1 mouse brains (Figure 3). These extracts con-tate a substantial amount of APP with the KLC antibody
tain both soluble and membrane proteins. Consistent(63-90) from fraction 8 in wild type, but only very little
with previous experiments, three independent microtu-from fraction 11. In contrast, while we could coimmuno-
bule motors, kinesin-I (detected with KLC antibodies),precipitate a substantial amount of APP from fraction
kinesin-II (detected with KIF3A antibody), and cyto-11 of KLC1 mutant gradients with the KLC antibody, we
could not coimmunoprecipitate appreciable amounts of plasmic dynein (detected with a dynein intermediate
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with APP (Figure 1B). It is possible that in vivo there
exist different functional pools of APP associated with
KLCs; further work is needed to unravel these differ-
ences.
The C Terminus of APP Interacts with KLC
To determine whether the cytoplasmic C-terminal do-
main of APP was necessary for the interaction of APP
with kinesin-I, we conducted coimmunoprecipitation ex-
periments from extracts of normal CHO cells or CHO
cells overexpressing wild-type full-length APP (wtAPP)
or a C-terminal deletion of APP (DCAPP lacking 43 amino
acids from the 47 amino acid cytoplasmic domain)
(Perez et al., 2000) (Figure 4). Antibodies to KLC (63-
90) coimmunoprecipated a substantial fraction of APP
(compare IP versus supernatant in Figure 4) from normal
CHO cells and wtAPP CHO cells. In contrast, only aFigure 3. Binding of APP to Microtubules Depends on KLC
small amount of APP was coimmunoprecipitated fromMicrotubules were polymerized from wild-type (wt) or mutant (2/2)
the DCAPP CHO cells. The amount observed from themouse brain extracts (HSS) containing both soluble and membrane-
bound proteins. Either 2 mM AMP-PNP or 2 mM ATP was included. DCAPP CHO cells is comparable to the amount coimmu-
Microtubules and associated proteins were pelleted by centrifuga- noprecipitated from control CHO cells and is most likely
tion, and equal volumes of pellet (P) containing microtubule-associ- to be the endogenous full-length APP based on its
ated proteins and supernatant (S) were analyzed by Western blotting slightly slower mobility than the DCAPP. The no antibodyusing antibodies to tubulin, KLC (63-90), APP (22C11), dynein inter-
control did not coimmunoprecipitate any detectablemediate chain (DIC), and KIF3A.
APP. In a complementary experiment, using the APP
antibody 22C11, a small amount of KLC was coimmuno-
precipitated from normal CHO cells and a larger amountchain antibody), exhibited greater binding to microtu-
bules in the presence of AMP-PNP than ATP; very little from the wtAPP CHO cells; only amounts comparable
to normal cells were coimmunoprecipitated from theof each motor protein was observed in the AMP-PNP
supernatant. There were no discernible differences in DCAPP CHO cells. Thus, these results suggest that the
C terminus of APP is necessary for complex formationthe microtubule binding behavior of the three microtu-
bule motors in the KLC1 mutant, except, as expected, with the KLC subunit of kinesin-I.
To test for direct interactions between the cyto-KLC1 itself was absent in the mutant. Examination of
APP revealed that it sedimented with microtubules, both plasmic C-terminal domain of APP and KLC, we con-
ducted in vitro binding assays using GST fusion proteinsin the presence of ATP and AMP-PNP in the wild-type
mouse brain extracts. Strikingly, APP did not cosedi- (Figure 5A). GST fused to full-length KLC1 (GST-KLC1)
or full-length KLC2 (GST-KLC2) was incubated with ament with microtubules in the presence of ATP or AMP-
PNP in the mutant KLC1 mouse brain extracts. Why APP protein consisting of the C-terminal tail of APP fused to
GFP (APP-GFP). APP-GFP bound to both GST-KLC1associates with microtubules in the presence of ATP is
unclear, but it is possible that APP preferentially associ- and GST-KLC2 but not to GST alone. In addition, the
GST-KLC1 and GST-KLC2 proteins also bound to anates with the small fraction of kinesin-I that we and
others routinely observe to bind microtubules even with overlapping region of the C-terminal stalk of KIF5B
(KIF5B-His) as previously reported (Gauger and Gold-ATP present. Nonetheless, together these results sug-
gest that the association of APP with microtubules is stein, 1993; Diefenbach et al., 1998). In contrast, the
C-terminal tail of the kinesin-II subunit, KIF3A (KIF3A-His)strongly dependent on KLC. It is surprising that the rela-
tive dependence of APP association with microtubules or another kinesin-like motor, KIF21A, or GFP alone did
not bind GST-KLC1 and GST-KLC2. We also tested theupon KLC1 and KLC2 is different than might be expected
from the coimmunoprecipitation experiments, which binding of APP-GFP to GST-KLC1 using five different
buffer conditions including high salt concentrations (seesuggest that both KLC1 and KLC2 can exist in a complex
Figure 4. The C Terminus of APP Is Required
for Complex Formation with Kinesin-I
Cell lysates from normal CHO cells (CHO) or
CHO cells overexpressing wild-type full-
length APP (wtAPP) or a C-terminal deletion
of APP (DCAPP) were immunoprecipitated
with either no antibody control or antibodies
recognizing KLC (63-90) or APP (22C11).
Equal amounts of the immunoprecipitate (IP)
and the remaining supernatant (Supe) were
loaded onto SDS–polyacrylamide gels and
then analyzed by Western blots using KLC (63-90) and APP (22C11) antibodies. For the KLC blot, we show an exposure selected to minimize
overexposure of the bands from wtAPP and DCAPP CHO cells. The KLC band from the normal CHO cells immunoprecipitated with KLC
antibody is thus faint and appears only on a longer exposure (data not shown).
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Figure 5. Direct Binding of the C-Terminal Tail of APP to the TPR Domain of KLC
(A) C terminus of APP directly binds KLC. Purified GST, GST-KLC1, and GST-KLC2 bound to glutathione agarose beads were incubated with
purified fusion proteins consisting of the C-terminal tail of APP (APP-GFP), KIF5B (KIF5B-His), KIF3A (KIF3A-His), KIF21A (KIF21A-His), or
GFP alone. The unbound protein was saved, and the beads were washed and bound proteins eluted with glutathione. The bound and unbound
proteins were analyzed by SDS–PAGE followed by Western blotting with antibodies to either GFP or the His-tag. For KIF5B-His, the lower
band is a degraded product that still retains the KLC binding site.
(B) Binding analysis of APP C terminus to KLC1. Increasing amounts of APP-GFP were added to 60 nM GST-KLC1, and the Kd determined
by curve-fitting as described in Experimental Procedures. Also shown are predicted curves for cases where Kd 5 1 nM or 50 nM.
(C) Binding analysis of APP C terminus to KLC2. Increasing amounts of APP-GFP were added to 60 nM GST-KLC2, and the Kd determined
by curve-fitting as described in Experimental Procedures. Also shown are predicted curves for Kd 5 1 nM or 50 nM.
(D) Monoclonal antibody to the TPR domain of KLC (KLC-All) inhibits APP binding to KLC. Binding of purified GST, GST-KLC1, and GST-
KLC2 to APP-GFP in the presence of no antibody or monoclonal KLC-All (IgG1) or monoclonal 63-90 (IgG1) antibodies. Bound and unbound
proteins were analyzed as above using the GFP antibody.
(E) C terminus of APP directly binds the TPR domain of KLC1. Purified GST fusion proteins of either the N-terminal coiled-coil domain of
KLC1 (GST-CC) or the TPR domains of KLC1 (GST-TPR) or GST alone were incubated with APP-GFP or KIF5B-His or GFP alone and the
bound and unbound proteins analyzed using antibodies to the GFP and His tags.
Experimental Procedures). We observed that APP-GFP domains (Figure 5D). The monoclonal antibody 63-90
recognizes an epitope within the N-terminal 50 aminobound to GST-KLC1, but not to GST alone, whereas
GFP alone did not bind to either GST fusion protein acids of KLC, whereas the monoclonal antibody KLC-
All recognizes the TPR domains of KLC (Stenoien andunder any of the five tested conditions.
To estimate the binding stoichiometry and binding Brady, 1997); both the antibodies are IgG1 isotypes (S.
Brady, personal communication). Addition of the KLC-affinity of APP for KLC, we conducted binding experi-
ments over a wide range of APP-GFP concentrations All antibody inhibited the binding of APP-GFP to both
GST-KLC1 and GST-KLC2 (Figure 5D). In contrast, addi-(Figures 5B and 5C). Addition of increasing amounts of
APP resulted in saturable binding to KLC with a stoichi- tion of the isotype-matched monoclonal antibody 63-90
did not affect the binding.ometry of 2 APP per 1 KLC. The apparent Kd for binding
of APP was estimated by curve-fitting (see Experimental To test directly if the C terminus of APP interacts with
the TPR domains of KLC, we did GST pulldown assaysProcedures) and was found to be approximately 18 6
4 nM for KLC1 and 16 6 3 nM for KLC2. Thus, these using GST fusion proteins of KLC1 that contained either
the TPR domains (GST-TPR) or only the N-terminalresults suggest that the C terminus of APP can interact
directly with KLC with a high affinity. coiled-coil region (GST-CC) (Figure 5E). Purified APP-
GFP protein bound to GST-TPR and not to GST-CC orTo examine if the N-terminal domain of KLC or the
TPR domain of KLC was responsible for the interaction to GST alone. In contrast, a KIF5B construct that con-
tains part of a region previously found to bind to KLCof APP with KLC, we tested whether the binding of APP-
GFP to GST-KLC1 or GST-KLC2 could be inhibited by (Gauger and Goldstein, 1993; Diefenbach et al., 1998)
bound to GST-CC and not to GST-TPR. GFP alone didmonoclonal antibodies that recognize either of the two
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Figure 6. Decreased Axonal Transport of APP in Sciatic Nerves of KLC1 Mutant Mice
(A) Sciatic nerves from wild-type (wt) and mutant (2/2) KLC1 littermate mice were dissected, homogenized, and analyzed by quantitative
Western blotting using antibodies to APP (22C11 and 4G8), GAP43, and non-kinesin-I cargoes, synaptophysin (SYP), and synaptotagmin
(SYT). The normalized relative amount of each protein (bar graphs) in wild-type (wt, black bars) was set to 1.0, and the amount of each protein
present in the KLC1 mutant (2/2, gray bars) was determined using actin as an internal normalization and loading control. For APP, the lower
bands seen on the immunoblot were also included in the quantitation shown in the bar graph. One representative experiment is shown; we
observed less than 5% standard deviation in four independent experiments using four different matched pairs of mice.
(B) The sciatic nerves of wild-type (wt) and mutant (2/2) KLC1 mice were ligated unilaterally at the midpoint. Six hours later the proximal and
distal halves of the nerve on either side of the ligature were dissected from the unligated (control) and ligated nerves of each animal. The
proximal and distal halves were pooled, homogenized, protein concentration measured, and equal amounts of protein were analyzed by
SDS–PAGE and Western blots using antibodies to APP (22C11 shown; 4G8 not shown), dynein intermediate chain (DIC), tubulin, KIF5B,
GAP43, and synaptotagmin.
not bind to any of the GST fusion proteins. Thus, these pared to wild-type when we probed the sciatic extracts
with the APP antibody 22C11 (Figure 6). In the KLC1results demonstrate that the C terminus of APP directly
binds to the TPR domains of KLC. mutant, we sometimes observed smaller molecular
weight bands in the Western blots with APP, which could
be degraded or incorrectly processed APP fragments;Axonal Transport of APP Is Decreased in Sciatic
Nerves of KLC1 Mutant Mice the reduction seen in the KLC1 mutant in the bar graph
includes these fragments. Since there is the possibilityTo test the in vivo significance of the formation of a
complex between APP and kinesin-I, we compared the that the APP antibody 22C11 could cross-react with
proteins related to APP such as APLP1 or APLP2 (Deamount of APP present in sciatic nerves in wild-type
and mutant KLC1 mice (Figure 6A). Since sciatic nerve Strooper and Annaert, 2000), we also did immunoblot-
ting with the monoclonal antibody 4G8, which recog-is composed of sensory and motor neuron axons, some
Schwann cell material, but not neuronal cell bodies, this nizes amino acids 17–24 of the amyloid-b domain in APP
and thus does not cross-react with APLP1 or APLP2.measurement gave an initial estimate of axonal content
of APP. Although the total amount and size of APP in Immunoblotting with 4G8 also gave the same result; that
is, there is a significant decrease in the amount of APPbrain extracts from the KLC1 mutant mice was normal
(e.g., Figure 3, HSS), the amount of APP present in sciatic that is present in the sciatic nerves of the KLC1 mutant.
We also probed the sciatic nerve extracts for synapticnerves of KLC1 mutants was significantly reduced com-
Kinesin-I-Dependent Axonal Transport of APP
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vesicle markers and other transported membrane pro- Discussion
teins. The relative amounts of synaptophysin and synap-
totagmin, which are presynaptic cargoes likely to be Our results suggest that axonal transport of APP re-
quires the formation of a complex containing kinesin-Itransported by a different kinesin-like motor, UNC104/
KIF1A (Otsuka et al., 1991; Okada et al., 1995; Yonekawa and APP by direct binding of APP to the KLC subunit
of kinesin-I. This conclusion is supported by severalet al., 1998) were unchanged in KLC1 mutants compared
to wild type, suggesting that cargoes of other motor lines of evidence, including coimmunoprecipitation, su-
crose gradients, and direct in vitro binding experiments.proteins are unaffected. Strikingly, we also observed
a significant decrease in the amount of a previously In addition, association of APP with microtubules and
axonal transport of APP is greatly diminished in a mouseproposed kinesin-I cargo, GAP43, a neuronal membrane
protein whose transport into axons was previously mutant of KLC1, thus providing compelling evidence
for the role of KLC in the microtubule-based axonalshown to be inhibited in cultured hippocampal neurons
treated with KHC antisense oligonucleotides (Ferreira et transport of APP in neurons. Thus, our work provides
direct molecular evidence about the mechanism of axo-al., 1992). These results suggest that there is decreased
axonal transport of APP and GAP43 in the KLC1 mutant, nal transport of APP and identifies APP as a likely mem-
brane cargo receptor for kinesin-I.whereas bulk biosynthesis and axonal transport of other
non-kinesin-I membrane cargoes is unaffected.
To assess directly if the APP we assay by Western The Role of Kinesin-I in Axonal Transport of APP
blot of whole sciatic nerves reflects the anterograde Our studies confirm and extend earlier suggestions that
axonal transport population and to confirm that axonal kinesin-I might drive the fast anterograde axonal trans-
transport of APP is reduced in the KLC1 mutant, we port of APP. These suggestions were based on anti-
performed biochemical analyses of sciatic nerve ligation sense experiments that found decreased APP transport
experiments (Figure 6B). Sciatic nerves were ligated in when the expression of the KHC subunit of kinesin-I was
the middle for 6 hr and then proximal and distal halves inhibited in rabbit optic nerve or hippocampal neurons
relative to the point of ligature were assayed for accumu- (Ferreira et al., 1993; Amaratunga et al., 1995; Yamazaki
lation or depletion of APP and various marker proteins et al., 1995; Kaether et al., 2000). However, these earlier
previously shown to be part of anterograde, retrograde, studies are difficult to interpret since simultaneous inhi-
or slowly moving populations (reviewed in Goldstein and bition of the transport of the non-kinesin-I cargo, synap-
Yang, 2000). As previously reported, the anterograde tophysin (Okada et al., 1995), was also observed (Amara-
motor kinesin-I (detected using KIF5B antibody) exhibits tunga et al., 1995). Thus, our work showing a direct
massive accumulation on the proximal side of the liga- biochemical interaction between APP and KLC and the
ture and depletes on the distal side. The retrograde dramatic reduction of axonal transport of APP in a gene-
motor dynein (detected with the dynein intermediate targeted mouse mutant of KLC is the most direct in vivo
chain antibody) accumulates only modestly or remains evidence for the role of kinesin-I in the transport of APP.
the same in the proximal and distal halves of the ligation. Recently, yeast two-hybrid analyses identified a pro-
The slow transport marker tubulin exhibits equal abun- tein called PAT1 that binds to the C-terminal basolateral-
dance in proximal and distal halves of ligated and control sorting signal of APP and was suggested to play a role
nerves as expected. In wild-type mice, we observed a in the transport of APP (Zheng et al., 1998). Interestingly,
substantial increase of APP on the proximal side after a PAT1 expressed in transfected cells cosediments with
6 hr ligation accompanied by a striking and reproducible microtubules and also possesses TPR repeat domains
depletion in the distal half (data shown for antibody similar to those found in KLC and other TPR-containing
22C11; comparable data were obtained with 4G8 but proteins. However, the TPR domains of PAT1 are only
are not shown). Similarly, we observed a significant in- 26% identical to the TPR domains of KLCs, and the
crease of GAP43 on the proximal side accompanied by overall sequence of PAT1 is only 15% identical to KLC.
depletion in the distal side. These data suggest that In addition, although PAT1 is reported to associate with
most of the APP (and GAP43) detected by Western blot a 110 kDa protein, this protein is clearly not KHC (Zheng
of whole sciatic nerve is part of the moving fraction, et al., 1998). Thus, it appears that PAT1 is not a true
while only a small fraction of the APP is not moving or homolog of KLC, but instead may be a microtubule inter-
is contributed from nonneuronal Schwann cells present acting protein that also binds APP. Perhaps PAT1 has
in sciatic nerves. Analysis of comparable sciatic ligation a function at the nerve terminus after APP is delivered
experiments in KLC1 mutant mice revealed a significant there by kinesin-I, although whether PAT1 is expressed
decrease in the amount of APP that accumulated on the in neurons is unknown.
proximal side after ligation and an apparently smaller It is intriguing that overexpression of an APP homo-
relative depletion on the distal side compared to wild logue (APPL) in Drosophila neurons leads to axonal
type. The control markers tubulin, dynein, KIF5B, and blockage and neuronal dysfunction that is synergistic
synaptotagmin had the same behavior in the mutant as with overexpression of the microtubule-associated pro-
in wild type, suggesting a selective defect as expected. tein tau (Torroja et al., 1999). This axonal blockage phe-
We suggest that the residual transport of APP observed notype is similar to what is observed in Drosophila mu-
in the KLC1 mutant is mediated by the remaining KLC2, tants lacking known kinesin (Hurd and Saxton, 1996;
which is also known to be expressed in sciatic nerve Hurd et al., 1996; Gindhart et al., 1998) and dynein (Bow-
axons (Rahman et al., 1999). Together, however, these man et al., 1999; Martin et al., 1999) motor subunits or
results suggest that the axonal transport of APP is other membrane proteins that bind kinesin-I (Bowman
et al., 2000). Besides the phenotypic similarity betweengreatly decreased in a KLC1 mutant.
Neuron
456
APPL overexpression and mutations in microtubule mo- binding to KLC is inhibited by the KLC-All antibody,
which binds specifically to the TPR domain of KLC (Ste-tor subunits, a genetic interaction between APPL and
the KHC gene was also demonstrated (Torroja et al., noien and Brady, 1997), is similar to recent work on the
SYD protein. The SYD protein directly interacts with the1999), further supporting a direct functional association
of APP and kinesin-I. TPR domain of KLC by yeast two-hybrid analyses and
the KLC-All antibody also inhibits binding of SYD to KLC
in GST pulldown experiments (Bowman et al., 2000).Is APP a Membrane Cargo Receptor
Strikingly, in an in vitro organelle motility system, thefor Kinesin-I?
KLC-All antibody inhibits the binding of kinesin-I toOne of the most poorly understood aspects of microtu-
membranes and blocks fast axonal transport, while nobule-dependent trafficking is the identity of the membra-
such effects were seen with the 63-90 antibody, whichnous cargo that each motor carries. It is thought that
recognizes the N-terminal domain of KLC (Stenoien andmotor-cargo recognition may require three players: the
Brady, 1997). Together, these results demonstrate thatmotor proteins, a cargo-bound receptor, and accessory
the TPR domains of KLC directly interact with mem-components. Our results suggest that APP may be a
brane-associated proteins of vesicular cargo.membrane cargo receptor for kinesin-I and might link
Although our data in isolation are most consistentkinesin-I to a particular subset of axonal transport vesi-
with the simple suggestion that the function of the KLCcles. This idea is consistent with the finding that APP,
subunit of kinesin-I is to directly bind cargo receptora kinesin-I cargo, is enriched in Rab5-positive vesicles,
proteins such as APP, previous studies of the relativewhereas there is virtually no APP present in synaptophy-
roles of KLC and KHC in cargo attachment and motorsin positive vesicles that are most likely cargoes for the
regulation have yielded apparently contradictory re-UNC104/KIF1A kinesin (Otsuka et al., 1991; Okada et
sults. For example, while antibody inhibition studiesal., 1995; Ikin et al., 1996; Yonekawa et al., 1998). These
suggest that KLC is needed for interaction of kinesin-Idata suggest that different motors could interact with
with membranes (Stenoien and Brady, 1997), anotherdifferent membrane cargo receptors on particular sub-
study showed that KHC alone is sufficient to bind mem-sets of axonal transport vesicles.
branes (Skoufias et al., 1994). This latter finding is con-One previously reported potential receptor for kine-
sistent with recent work on a null mouse mutant of KLC1sin-I was kinectin, an integral membrane protein that is
that found KHC accumulation in the absence of KLC atlocalized to the endoplasmic reticulum (Toyoshima et
the Golgi apparatus, a presumed site of cargo transportal., 1992; Kumar et al., 1995). However, proteins other
initiation (Rahman et al., 1999). This apparent bindingthan kinectin might be important for axonal transport
of KHC to potential cargoes in vivo, in the absence ofsince kinectin has been reported to be absent from ax-
KLC, is also consistent with work on fungal kinesin-I,ons (Toyoshima and Sheetz, 1996). In addition, no direct
which has no KLC subunit, yet appears to be capableconnection between kinectin and either subunit of
of cargo binding (Steinberg and Schliwa, 1995). Therekinesin-I has been demonstrated, and kinectin is not
has also been conflicting evidence about whether KLC,found in C. elegans or Drosophila (Rubin et al., 2000).
or the tail of KHC, or both repress kinesin-I motor activityRecently, analysis of an axonal transport mutant in
in the absence of membrane or cargo binding (VerheyDrosophila led to the identification of a novel membrane-
et al., 1998; Coy et al., 1999; Friedman and Vale, 1999;associated protein, Sunday-driver (SYD), which may
Stock et al., 1999). The inconsistencies among thesealso be a membrane receptor for kinesin-I (Bowman
studies could be attributable to the various experimentalet al., 2000). GFP-tagged mammalian SYD localized to
systems used. However, we propose the following sim-tubular and vesicular elements that costained with
ple and testable unifying hypothesis that accounts forkinesin-I and Golgi markers, suggesting that SYD might
virtually all of the results described above including oursfunction as a membrane-associated receptor for the
on APP and SYD. We suggest that both KLC and theaxonal transport of post-Golgi vesicles. Thus, both APP
tail of KHC combine to fully repress motor activity, thatand SYD could be membrane cargo receptors for
the tail of KHC binds relatively indiscriminately to mem-kinesin-I in axonal transport and post-Golgi transport.
brane cargoes, and that KLC interaction with specificFurther work is needed to understand the functional
membrane proteins (such as APP or SYD) relieves motorrelationship of these two proteins.
repression and activates transport. Thus, the role of
KLC may be to provide specificity for cargo binding andWhat is the Role of KLC in the Interaction
transport, perhaps via an activation function. Clearly,of Kinesin-I with Cargo?
further work is needed to test this model rigorously.Our studies of APP suggest that KLC interacts with
membrane-associated proteins through one or more of
its TPR repeat domains. The binding stoichiometry that Significance of APP Interaction with Kinesin-I
in Alzheimer’s Diseasewe observe of two APP molecules per KLC fits well
with the atomic structure of other TPR domains, which There are numerous suggestions that aberrant traffick-
ing or transport of APP may contribute to the develop-suggest that three TPR repeats fold together to bind
one ligand (Blatch and Lassie, 1999; Scheufler et al., ment of AD (reviewed in Checler, 1995; Selkoe, 1998;
Sinha and Lieberburg, 1999). Our finding of a direct inter-2000). The KLC construct we used has six TPR repeats,
so the observed binding stoichiometry fits the theoreti- action of APP and the microtubule transport machinery
lead to the intriguing suggestion that abnormal interac-cal binding saturation that is predicted from the atomic
structure. It is intriguing that our observation that APP tions of APP and kinesin-I could play a role in the patho-
genesis of AD, perhaps by blocking or otherwise interfer-directly binds to the TPR domain of KLC and that APP
Kinesin-I-Dependent Axonal Transport of APP
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499–783 of KIF5B, the KIF3A-His fusion protein contained aminoing with normal axonal transport. Future studies using
acids 560–709, the KIF21A-His fusion protein contained amino acidsAPP transgenic and kinesin-I mutant mice will help eluci-
1124–1355, and all three were generated in pET-23b (Novagen). Alldate the significance of our findings for the pathology
the fusion proteins were expressed in bacteria and purified by Ni-
of AD. NTA-agarose as previously described (Marszalek et al., 1999).
Experimental Procedures
GST Binding Assay
GST binding assays were done as previously described (Tai et al.,Antibodies
1999) with minor modifications. Purified GST, GST-KLC1, and GST-For Western blots, the monoclonal antibody 63-90 (Stenoien and
KLC2 bound to glutathione agarose beads were incubated with 10Brady, 1997), which recognizes KLC1 and KLC2 was used at 1:1000,
mg of indicated purified fusion protein in 150 ml buffer B (20 mMthe polyclonal KIF5A, KIF5B, and KIF5C antibodies (prepared by C.
Tris-Cl [pH 7.5], 50 mM KCl, 100 mM NaCl, 2 mM CaCl2, 2 mM MgCl2,Xia and G. Stokin, unpublished data) were used at 1:100, the APP
5 mM DTT, 1% BSA, and protease inhibitors) for 1 hr at 48C. Formonoclonal antibody 22C11 (Chemicon) was used at 1:500, the 4G8
the antibody inhibition experiments, the antibody was prebound toAPP monoclonal antibody (Syntek) was used at 1:500, the tubulin
the beads for 1 hr at 48C and then incubated for 1 hr with themonoclonal antibody (DM1A, Sigma) was used at 1:5000, the cyto-
indicated protein. The unbound protein (in 150 ml total volume) wasplasmic dynein intermediate chain (DIC) monoclonal antibody
saved, and the beads were washed three times with buffer B. Bound(Chemicon) was used at 1:1000, the GFP monoclonal antibody
proteins were eluted with 50 ml of elution buffer (50 mM glutathione,(Clonetech) was used at 1:500, the His-tag antibody (Qiagen) was
50 mM Tris-Cl [pH 8.0]). The bound (50 ml) and unbound (50 ml, i.e.,used at 1:500, the KIF3A monoclonal antibody (K2.4, Babco) was
one-third of total volume) proteins were then analyzed by SDS–used at 1:1000, the synaptophysin monoclonal antibody (SY38,
PAGE followed by Western blotting. We also tested the binding ofBoehringer) was used at 1:200, the GAP43 monoclonal antibody
APP-GFP or GFP alone to either GST-KLC1 or GST using four other(Boehringer) was used at 1:1000, the synaptotagmin monoclonal
buffers than buffer B, namely (1) buffer B without Ca21, (2) buffer Bantibody (Stressgen) was used at 1:500, and the actin monoclonal
plus 500 mM NaCl plus 1% NP-40, (3) buffer A from sucroseantibody (Sigma) was used at 1:5000. The KLC1 and KLC2 specific
gradients (10 mM HEPES [pH 7.3], 0.5 mM EGTA, 0.5 mM MgCl2),polyclonal antibodies were previously described (Rahman et al.,
and (4) PBS (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4x7H2O, 1.41998). The C-terminal APP polyclonal antibody was from Chemicon
mM KH2PO4).(AB5352). The KLC-All monoclonal antibody a generous gift from
To estimate binding stoichiometry and binding affinity, increasingScott Brady (Stenoien and Brady, 1997).
concentrations of APP-GFP were incubated with known amounts
of the GST fusion proteins, and bound APP was separated from freeCoimmunoprecipitation Analyses
by sedimentation as above. The amounts of bound versus unboundCoimmunoprecipitation from wild-type and mutant KLC1 littermates
(free) proteins were calculated using quantitative Western blots cali-mouse brain extracts and sciatic nerve extracts was done as de-
brated by multiple exposures of various dilutions of purified proteinsscribed previously (Rahman et al., 1999), except the homogenization
to ensure that relative measurements were made in the linear regionbuffer was NP-40 lysis buffer (1% NP-40, 150 mM NaCl, 50 mM Tris
of detection for each probe. Dissociation constants were estimated[pH 8.0]). Extracts from the normal CHO cells and the wild-type full-
from the binding data by nonlinear fitting to the following equation:length APP overexpressing CHO cells, and the C-terminal deleted
PL 5 {(Po 1 Lo 1 Kd) 2 [(Po 1 Lo 1 Kd)2 2 4PoLo]1⁄2}/2 using GraFit 4APP overexpressing CHO cells (obtained from E. Koo) were made
software (Erithacus Software), where Po 5 total KLC, PL 5 boundby homogenizing in NP-40 lysis buffer and coimmunoprecipitations
APP-KLC, Lo 5 total APP, and Kd 5 dissociation constant for thedone as previously described (Rahman et al., 1999).
APP-KLC complex. We used this explicit quadratic equation instead
of more commonly used Scatchard analyses, because the standardSucrose Gradients
Scatchard equation, PL 5 Po 2 Kd x (PL/L), assumes that ligandSucrose gradient analyses of mouse brain membrane-associated
concentration does not become significantly depleted as a resultproteins was done with minor modifications to the protocol de-
of ligand binding. Such an assumption could not be made in ourscribed previously (Rahman et al., 1999). Briefly, mouse brains from
experimental setup.wild-type and mutant KLC1 littermates were homogenized in buffer
A (10 mM HEPES [pH 7.3], 0.5 mM EGTA, 0.5 mM MgCl2, 50 mM
Axonal Transport in Sciatic NervesATP) without detergent and spun at 100,000 3 g; the pellet was
Sciatic nerves from wild-type and KLC1 mutant mice that werethen solubilized in buffer A plus 0.5% NP-40 and spun at 100,000 3
littermates (Rahman et al., 1999) were dissected and homogenizedg, and the resulting supernatant was top loaded onto a 5%–20%
in NP-40 lysis buffer and then spun at 3,000 3 g and the supernatantlinear sucrose gradient, fractions were collected, and protein sam-
collected. Equal amounts of protein were analyzed on SDS–PAGEples analyzed by quantitative Western blotting as previously de-
followed by quantitative Western blotting. Sciatic ligation experi-scribed (Rahman et al., 1999).
ments were done as previously described (Hanlon et al., 1997). In
brief, one sciatic nerve from each of four wild-type or four mutantMicrotubule Binding Assays
KLC1 mice were ligated approximately in the middle; the other nerveMicrotubule binding assays were done as previously described
was left as an unligated control. Six hours after the ligation, animals(Hanlon et al., 1997), except mouse brains from wild-type and mutant
were sacrificed, and the proximal and distal halves of the nerveKLC1 littermates were homogenized in PEM buffer (80 mM PIPES
flanking the ligature were dissected, pooled, and homogenized as[pH 6.8], 2 mM MgCl2, 2 mM EGTA) containing 1% TX-100 and
described above; the unligated nerve was treated similarly. Theprotease inhibitors. Equal volumes of the pellet (containing microtu-
protein concentration was measured and equal amounts of proteinbules and sedimented proteins) and supernatant were analyzed on
loaded onto SDS–polyacrylamide gels and analyzed by WesternSDS–PAGE followed by Western analyses.
analyses.
Purification of Fusion Proteins
The GST fusion proteins (GST, GST-KLC1, and GST-KLC2) were Acknowledgments
purified as previously described (Rahman et al., 1998). The GST
fusion proteins of the TPR domains (GST-TPR) contained amino We thank Dr. Scott Brady for providing the 63-90 and KLC-All mono-
clonal antibodies, Dr. Roger Tsien for providing the His-taggedacids 167–541 of KLC1, whereas the GST fusion protein containing
the N-terminal coiled-coil domain of KLC (GST-CC) contained amino pRSETb-EGFP vector, and Dr. Joe Marszalek for providing the puri-
fied KIF3A-His and KIF21A-His proteins. We thank Dr. Edward Kooacids 30–200; both were purified as previously described (Rahman
et al., 1998). The APP-GFP fusion protein construct contained the for providing the APP overexpressing CHO cell lines and for valuable
discussions. We are indebted to Liz Roberts for invaluable assis-C-terminal 42 amino acids of human APP (APP cDNA provided by
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